Down's syndrome protects against breast cancer: Is a constitutional cell microenvironment the key?
Authors:
Open Access
- 25 August 2004
- journal article
- letter
- Published by Wiley in International Journal of Cancer
- Vol. 113 (1) , 168-170
Abstract
No abstract availableFunding Information
- Fondation Jérôme Lejeune
This publication has 18 references indexed in Scilit:
- Tumor reversion: Correction of malignant behavior by microenvironmental cuesInternational Journal of Cancer, 2003
- Role of tissue stroma in cancer cell invasionThe Journal of Pathology, 2003
- Are solid tumours different in children with Down's syndrome?International Journal of Cancer, 2003
- Relevance of drug uptake, cellular distribution and cell membrane fluidity to the enhanced sensitivity of Down's syndrome fibroblasts to anticancer antibiotic—mitoxantroneBiochimica et Biophysica Acta (BBA) - Biomembranes, 2003
- Beta 1 integrin activation mediates adhesive differences between trisomy 21 and non‐trisomic fibroblasts on type VI collagenAmerican Journal of Medical Genetics, 2002
- High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumoursEuropean Journal of Human Genetics, 2001
- Enhancement of matrix metalloproteinase (MMP)‐2 activity in gingival tissue and cultured fibroblasts from Down's syndrome patientsOral Diseases, 2001
- Risks of leukaemia and solid tumours in individuals with Down's syndromeThe Lancet, 2000
- Fibroblasts Can Modulate the Phenotype of Malignant Epithelial Cellsin VitroExperimental Cell Research, 1997
- Leukemia and other Cancers, Anomalies and Infections as Causes of Death in Down's Syndrome in the United States during 1976Developmental Medicine & Child Neurology, 1982